Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2011-03-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Up to 75 subjects, ages 18-30 and 60-75 years will be invited to participate. Subjects will undergo a complete audiological evaluation done to assign them into one of three arms/groups of up to15 subjects each. Arms will be composed of young subjects with normal hearing (YNH), older subjects with normal hearing (ONH) and older subjects with mild hearing impairment (OHI). Each subject will be asked to listen to between 18 and 26 non-overlapping tones each 30ms in duration followed by a 70ms silent interval. Target tones and tone complexes (T1 and T2) will be embedded in this stream. Sequences could contain (in equal probability) a) no target, b) T1 only, c) T2 only or d) both targets. At the end of each stream, the subject will be required to make an untimed judgment about whether the stream contained T1 (yes/no) and T2 (yes/no). This project is self-paced. The hypothesized findings are that young listeners without hearing impairment will have more difficulty reporting on T2 when it follows T1 by approximately 200-400ms than at any other interval. However, older listeners without hearing impairment will demonstrate a more prolonged period of interference (\>400ms) with slightly poorer performance overall while older listeners with hearing impairment will have an even longer lasting period of processing interference and overall larger deficit (poorer performance) suggesting that increasing age and hearing impairment combine to reveal significant processing deficits for this group. These results would provide a much needed explanation of the ways in which rapid processing (precisely what speech is) is degraded by hearing impairment, aging, and a combination of the two.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
young normal hearing
No interventions assigned to this group
Group 2
older normal hearing
No interventions assigned to this group
Group 3
older hearing impaired
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal hearing or
* Mild to moderate hearing loss
* No major medical or memory problems
Exclusion Criteria
* Conductive or mixed hearing loss.
* Hearing loss worse than 55dB in either ear.
* Taking medication known to alter concentration or alertness
* Inability to learn task after practice
* Major medical or psychological disorder
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marilyn L Dille, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Portland Health Care System, Portland, OR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Portland Health Care System, Portland, OR
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C6928-P
Identifier Type: -
Identifier Source: org_study_id